Search Results Search Sort by RelevanceMost Recent Case and Commentary Jul 2003 Drug Company Sponsorship of Clinical Conferences, Commentary 2 Ashley Wazana, MD Virtual Mentor. 2003;5(7):242-246. doi: 10.1001/virtualmentor.2003.5.7.ccas1-0307. Case and Commentary Jul 2003 Clinician and Researcher, Commentary 1 Timothy F. Murphy, PhD Virtual Mentor. 2003;5(7):247-250. doi: 10.1001/virtualmentor.2003.5.7.ccas2-0307. Case and Commentary Jul 2003 Clinician and Researcher, Commentary 2 Matthew Wynia, MD Virtual Mentor. 2003;5(7):251-254. doi: 10.1001/virtualmentor.2003.5.7.ccas2-0307. In the Literature Jul 2003 Financial Conflicts of Interest in Biomedical Research Jeremy Spevick Virtual Mentor. 2003;194-196. doi: 10.1001/virtualmentor.2003.5.7.jdsc1-0307. Medical Education Jul 2003 Commercial Support for Continuing Medical Education Murray Kopelow, MD Virtual Mentor. 2003;5(7):255-259. doi: 10.1001/virtualmentor.2003.5.7.medu1-0307. State of the Art and Science Jun 2003 Reducing the Effects of Low Health Literacy Faith Lagay, PhD Virtual Mentor. 2003;5(6):222-224. doi: 10.1001/virtualmentor.2003.5.6.cprl1-0306. State of the Art and Science Jul 2003 Treating Hypertension Audiey C. Kao, MD, PhD Virtual Mentor. 2003;5(7):265-267. doi: 10.1001/virtualmentor.2003.5.7.cprl1-0307. Health Law Jul 2003 Is it Legal for a Physician to Receive Payment for Prescribing a Drug? Kristin A. Sorenson Virtual Mentor. 2003;5(7):260-262. doi: 10.1001/virtualmentor.2003.5.7.hlaw1-0307. Policy Forum Jul 2003 Undergraduate and Graduate Medical Education and the Pharmaceutical Industry Greg E. Manship, MDiv, MA Virtual Mentor. 2003;5(7):268-272. doi: 10.1001/virtualmentor.2003.5.7.pfor1-0307. Policy Forum Jul 2003 The PhRMA Code: A New Roadmap for Industry-Physician Interactions Michael Scott Labson, Esq Virtual Mentor. 2003;5(7):273-275. doi: 10.1001/virtualmentor.2003.5.7.pfor2-0307. Pagination First page « First Previous page ‹ Previous … Page 13 Page 14 Page 15 Page 16 Current page 17 Page 18 Page 19 Page 20 Page 21 … Next page Next › Last page Last »
Case and Commentary Jul 2003 Drug Company Sponsorship of Clinical Conferences, Commentary 2 Ashley Wazana, MD Virtual Mentor. 2003;5(7):242-246. doi: 10.1001/virtualmentor.2003.5.7.ccas1-0307.
Case and Commentary Jul 2003 Clinician and Researcher, Commentary 1 Timothy F. Murphy, PhD Virtual Mentor. 2003;5(7):247-250. doi: 10.1001/virtualmentor.2003.5.7.ccas2-0307.
Case and Commentary Jul 2003 Clinician and Researcher, Commentary 2 Matthew Wynia, MD Virtual Mentor. 2003;5(7):251-254. doi: 10.1001/virtualmentor.2003.5.7.ccas2-0307.
In the Literature Jul 2003 Financial Conflicts of Interest in Biomedical Research Jeremy Spevick Virtual Mentor. 2003;194-196. doi: 10.1001/virtualmentor.2003.5.7.jdsc1-0307.
Medical Education Jul 2003 Commercial Support for Continuing Medical Education Murray Kopelow, MD Virtual Mentor. 2003;5(7):255-259. doi: 10.1001/virtualmentor.2003.5.7.medu1-0307.
State of the Art and Science Jun 2003 Reducing the Effects of Low Health Literacy Faith Lagay, PhD Virtual Mentor. 2003;5(6):222-224. doi: 10.1001/virtualmentor.2003.5.6.cprl1-0306.
State of the Art and Science Jul 2003 Treating Hypertension Audiey C. Kao, MD, PhD Virtual Mentor. 2003;5(7):265-267. doi: 10.1001/virtualmentor.2003.5.7.cprl1-0307.
Health Law Jul 2003 Is it Legal for a Physician to Receive Payment for Prescribing a Drug? Kristin A. Sorenson Virtual Mentor. 2003;5(7):260-262. doi: 10.1001/virtualmentor.2003.5.7.hlaw1-0307.
Policy Forum Jul 2003 Undergraduate and Graduate Medical Education and the Pharmaceutical Industry Greg E. Manship, MDiv, MA Virtual Mentor. 2003;5(7):268-272. doi: 10.1001/virtualmentor.2003.5.7.pfor1-0307.
Policy Forum Jul 2003 The PhRMA Code: A New Roadmap for Industry-Physician Interactions Michael Scott Labson, Esq Virtual Mentor. 2003;5(7):273-275. doi: 10.1001/virtualmentor.2003.5.7.pfor2-0307.